Personality change during depression treatment: A placebo-controlled trial

Archives of General Psychiatry

Volumn 66, Issue 12, 2009, Pages 1322-1330

  Tang, Tony Z ^a   DeRubeis, Robert J ^b   Hollon, Steven D ^c   Amsterdam, Jay ^b   Shelton, Richard ^c   Schalet, Benjamin ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EXTRAVERSION; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; NEUROSIS; PERSONALITY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RELAPSE; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; EXTRAVERSION (PSYCHOLOGY); HUMANS; NEUROTIC DISORDERS; OBSERVER VARIATION; PAROXETINE; PERSONALITY; PERSONALITY INVENTORY; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 73149092089     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2009.166     Document Type: Article

References (59)

1. Digman JM. Personality structure: emergence of the five-factor model. Annu Rev Psychol. 1990;41:417-440.
2. McCrae RR, Costa PT Jr. Personality trait structure as a human universal. Am Psychol. 1997;52(5):509-516.
3. Costa PT, McCrae RR. Revised NEO Personality Inventory and NEO Five-Factor Inventory: Professional Manual. Lutz, FL: Psychological Assessment Resources, Inc; 1992.
4. McCrae RR, Costa PT. A contemplated revision of the NEO Five-Factor Inventory. Pers Individ Dif. 2004;36:587-596.
5. Clark LA, Watson D, Mineka S. Temperament, personality, and the mood and anxiety disorders. J Abnorm Psychol. 1994;103(1):103-116.
6. Ormel J, Oldehinkel AJ, Vollebergh W. Vulnerability before, during, and after a major depressive episode: a 3-wave population-based study. Arch Gen Psychiatry. 2004;61(10):990-996.
7. Kendler KS, Kuhn J, Prescott CA. The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression. Am J Psychiatry. 2004;161(4):631-636.
8. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. A longitudinal twin study of personality and major depression in women. Arch Gen Psychiatry. 1993; 50(11):853-862.
9. Krueger RF, Caspi A, Moffitt TE, Silva PA, McGee R. Personality traits are differentially linked to mental disorders: a multitrait-multidiagnosis study of an adolescent birth cohort. J Abnorm Psychol. 1996;105(3):299-312.
10. Kendler KS, Gatz M, Gardner CO, Pedersen NL. Personality and major depression: a Swedish longitudinal, population-based twin study. Arch Gen Psychiatry. 2006;63(10):1113-1120.
11. Caspi A, Moffitt TE, Newman DL, Silva PA. Behavioral observations at age 3 years predict adult psychiatric disorders: longitudinal evidence from a birth cohort. Arch Gen Psychiatry. 1996;53(11):1033-1039.
12. Hirschfeld RM, Klerman GL, Lavori P, Keller MB, Griffith P, Coryell W. Premorbid personality assessments of first onset of major depression. Arch Gen Psychiatry. 1989;46(4):345-350.
13. Tellegen A, Lykken DT, Bouchard TJ Jr, Wilcox KJ, Segal NL, Rich S. Personality similarity in twins reared apart and together. J Pers Soc Psychol. 1988;54(6):1031-1039.
14. Jardine R, Martin NG, Henderson AS. Genetic covariation between neuroticism and the symptoms of anxiety and depression. Genet Epidemiol. 1984;1(2):89-107.
15. Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves LJ. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women: phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch Gen Psychiatry. 1995;52(5):374-383.
16. Kendler KS, Gardner CO, Gatz M, Pedersen NL. The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychol Med. 2007;37(3):453-462.
17. Hettema JM, Neale MC, Myers JM, Prescott CA, Kendler KS. A population-based twin study of the relationship between neuroticism and internalizing disorders. Am J Psychiatry. 2006;163(5):857-864.
18. Bagby RM, Levitan RD, Kennedy SH, Levitt AJ, Joffe RT. Selective alteration of personality in response to noradrenergic and serotonergic antidepressant medication in depressed sample: evidence of non-specificity. Psychiatry Res. 1999;86(3):211-216.
19. Ekselius L, von Knorring L. Changes in personality traits during treatment with sertraline or citalopram. Br J Psychiatry. 1999;174:444-448.
20. Brody AL, Saxena S, Fairbanks LA, Alborzian S, Demaree HA, Maidment KM, Baxter LR Jr. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine. J Clin Psychiatry. 2000;61(5):349-355.
21. Du L, Bakish D, Ravindran AV, Hrdina PD. Does fluoxetine influence major depression by modifying five-factor personality traits? J Affect Disord. 2002;71(1-3):235-241.
22. Santor DA, Bagby RM, Joffe RT. Evaluating stability and change in personality and depression. J Pers Soc Psychol. 1997;73(6):1354-1362.
23. Kramer PD. Listening to Prozac. New York, NY: Viking; 1993.
24. Agosti V, McGrath PJ. Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression. J Affect Disord. 2002;71(1-3):113-120.
25. Gracious KS. Do SSRIs affect personality traits? Br J Psychiatry. 1999;175:287.
26. Marchevsky D. Selective serotonin reuptake inhibitors and personality change. Br J Psychiatry. 1999;175:589-590.
27. Tse WS, Bond AJ. Serotonergic involvement in the psychosocial dimension of personality. J Psychopharmacol. 2001;15(3):195-198.
28. Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC, Terpstra J, Turner RA, Reus VI. Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry. 1998;155(3):373-379.
29. Melke J, Westberg L, Nilsson S, Landen M, Soderstrom H, Baghaei F, Rosmond R, Holm G, Björntorp P, Nilsson LG, Adolfsson R, Eriksson E. A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women. Arch Gen Psychiatry. 2003;60(10):1017-1023.
30. Strobel A, Gutknecht L, Rothe C, Reif A, Mössner R, Zeng Y, Brocke B, Lesch KP. Allelic variation in 5-HT1A receptor expression is associated with anxietyand depression-related personality traits. J Neural Transm. 2003;110(12):1445-1453.
31. Tauscher J, Bagby RM, Javanmard M, Christensen BK, Kasper S, Kapur S. Inverse relationship between serotonin 5-HT(1A) receptor binding and anxiety: a [(11)C]WAY-100635 PET investigation in healthy volunteers. Am J Psychiatry. 2001;158(8):1326-1328.
32. Sen S, Burmeister M, Ghosh D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet. 2004;127B(1):85-89.
33. Schinka JA, Busch RM, Robichaux-Keene N. A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol Psychiatry. 2004;9(2):197-202.
34. Young SN, Leyton M. The role of serotonin in human mood and social interaction: insight from altered tryptophan levels. Pharmacol Biochem Behav. 2002;71(4):857-865.
35. Huber R, Panksepp JB, Yue Z, Delago A, Moore P. Dynamic interactions of behavior and amine neurochemistry in acquisition and maintenance of social rank in crayfish. Brain Behav Evol. 2001;57(5):271-282.
36. Edwards DH, Kravitz EA. Serotonin, social status and aggression. Curr Opin Neurobiol. 1997;7(6):812-819.
37. DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, O'Reardon JP, Lovett ML, Gladis MM, Brown LL, Gallop R. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005;62(4):409-416.
38. Jarrett RB, Schaffer M, McIntire D, Witt-Browder A, Kraft D, Risser RC. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56(5):431-437.
39. DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD. Medications versus cognitive behavior therapy for severely depressed outpatients: mega-analysis of four randomized comparisons. Am J Psychiatry. 1999;156(7):1007-1013.
40. Quilty LC, De Fruyt F, Rolland JP, Kennedy SH, Rouillon PF, Bagby RM. Dimensional personality traits and treatment outcome in patients with major depressive disorder. J Affect Disord. 2008;108(3):241-250.
41. Bagby RM, Quilty LC, Segal ZV, McBride CC, Kennedy SH, Costa PT. Personality and differential treatment response in major depression: a randomized controlled trial comparing cognitive-behavioural therapy and pharmacotherapy. Can J Psychiatry. 2008;53(6):361-370.
42. Williams JB. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry. 1988;45(8):742-747.
43. Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiatry. 2000;57(4):311-317.
44. Greenberg RP, Bornstein R, Zborowski MJ, Fisher S, Greenberg ME. A metaanalysis of fluoxetine outcome in the treatment of depression. J Nerv Ment Dis. 1994;182(10):547-551.
45. Kirsch I, Moore TJ, Scoboria A, Nicholls SS. The emperor's new drugs: an analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prev Treat. 2002:5.
46. Kirsch I, Sapirstein G. Listening to Prozac but hearing placebo: a meta-analysis of antidepressant medication. Prev Treat. 1998:1.
47. Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O'Reardon JP, Lovett ML, Young PR, Haman KL, Freeman BB, Gallop R. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry. 2005;62(4):417-422.
48. American Psychological Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychological Association; 1994.
49. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC. The longitudinal interval follow-up evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987;44(6):540-548.
50. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
51. Cox DR, Oakes D. Analysis of Survival Data. London, England: Chapman & Hall; 1984.
52. Hollon SD, DeRubeis RJ, Evans MD. Causal mediation of change in treatment for depression: discriminating between nonspecificity and noncausality. Psychol Bull. 1987;102(1):139-149.
53. Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry. 2004;61(1):34-41.
54. Hellerstein DJ, Kocsis JH, Chapman D, Stewart JW, Harrison W. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality. Am J Psychiatry. 2000;157:1436-1444.
55. Practice guideline for the treatment of patients with major depressive disorder (revision): American Psychiatric Association. Am J Psychiatry. 2000;157(4) (suppl):1-45.
56. White KS, Barlow DH. Panic disorder and agoraphobia. In: Barlow DH, ed. Anxiety and Its Disorders. 2nd ed. New York, NY: Guilford; 2002:328-379.
57. Walsh BT. Pharmacological treatment of anorexia nervosa and bulimia nervosa. In: Fairburn CG, Brownell KD, eds. Eating Disorders and Obesity: A Comprehensive Handbook. 2nd ed. New York, NY: Guilford; 2002:325-329.
58. Jorm AF, Christensen H, Henderson AS, Jacomb PA, Korten AE, Rodgers B. Predicting anxiety and depression from personality: is there a synergistic effect of neuroticism and extraversion? J Abnorm Psychol. 2000;109(1):145-149.
59. Wade TD, Bulik CM, Prescott CA, Kendler KS. Sex influences on shared risk factors for bulimia nervosa and other psychiatric disorders. Arch Gen Psychiatry. 2004;61(3):251-256.